Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 912-920 , November 2005

Hemolytic Uremic Syndrome after Bone Marrow Transplantation: Clinical Characteristics and Outcome in Children

  • Gregory A. Hale

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • Corresponding Author InformationCorrespondence and reprint requests: Gregory A. Hale, MD, Department of Hematology/Oncology, St. Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794.
    • ,
  • Laura C. Bowman

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • ,
  • Richard J. Rochester

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Eli Benaim

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • ,
  • Helen E. Heslop

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • ,
  • Robert A. Krance

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • ,
  • Edwin M. Horwitz

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • Division of Experimental Hematology, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • John M. Cunningham

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • Division of Experimental Hematology, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Xin Tong

      Affiliations

    • Departments of Hematology/Oncology and Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Deo Kumar Srivastava

      Affiliations

    • Departments of Hematology/Oncology and Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Rupert Handgretinger

      Affiliations

    • Division of Stem Cell Transplantation, St. Jude Children’s Research Hospital, Memphis, Tennessee
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • ,
  • Deborah P. Jones

      Affiliations

    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
    • Division of Pediatric Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee

Received 23 July 2004 ,Accepted 28 July 2005.

References 

  1. Iacopino P , Pucci G , Arcese W , et al.   Severe thrombotic microangiopathy (an infrequent complication of bone marrow transplantation) . Bone Marrow Transplant . 1999;24:47–51
  2. Uderzo C , Fumagalli M , De Lorenzo P , et al.   Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation . Bone Marrow Transplant . 2000;26:1005–1009
  3. Pettitt AR , Clark RE . Thrombotic microangiopathy following bone marrow transplantation . Bone Marrow Transplant . 1994;14:495–504
  4. Fuge R , Bird JM , Fraser A , et al.   The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation . Br J Haematol. . 2001;113:58–64
  5. Matsuda Y , Hara J , Miyoshi H , et al.   Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children . Bone Marrow Transplant . 1999;24:919–923
  6. Roy V , Rizvi MA , Besely SK , et al.   Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation (an analysis of associated conditions and clinical outcomes) . Bone Marrow Transplant . 2001;27:641–646
  7. Elliott MA , Nichols WL , Plumhoff EA , et al.   Posttransplantation thrombotic thrombocytopenic purpura (a single-center experience and a contemporary review) . Mayo Clin Proc. . 2003;78:421–430
  8. Hongeng S , Krance RA , Bowman LC , et al.   Outcomes of transplantation with matched sibling and unrelated-donor bone marrow in children with leukemia . Lancet . 1997;350:767–770
  9. Horwitz EM , Prockop DJ , Gordon PL , et al.   Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta . Blood . 2001;97:1227–1231
  10. Glucksberg H , Storb R , Fefer A , et al.   Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors . Transplantation . 1974;18:295–304
  11. Heslop HE , Benaim E , Brenner MK , et al.   Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1 . Lancet . 1995;346:805–806
  12. Rooney CM , Smith CA , Ng C , et al.   Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation . Lancet . 1995;345:9–13
  13. Prentice RL , Kalbfleisch JD , Peterson AV , et al.   The analysis of failure times in the presence of competing risks . Biometrics . 1978;34:541–554
  14. Gray RJ . A class of k-sample tests for comparing the cumulative incidence of a competing risk . Ann Stat. . 1988;16:1141–1154
  15. Fine JP , Gray RJ . A proportional hazards model for the subdistribution of a competing risk . J Am Stat Assoc. . 1999;94:496–509
  16. Juckett MB , Cohen EP , Keever-Taylor CA , et al.   Loss of renal function following bone marrow transplantation (an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors) . Bone Marrow Transplant . 2001;27:451–456
  17. Poulsom R , Forbes SJ , Hodivala-Dilke K , et al.   Bone marrow contributes to renal parenchymal turnover and regeneration . J Pathol. . 2001;195:229–235
  18. Rookmaaker MB , Tolboom H , Goldschmeding R , et al.   Bone marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy . Blood . 2002;99:1095
  19. Furlan M , Robles R , Galbusera M , et al.   von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome . N Engl J Med. . 1998;339:1578–1584
  20. Tsai HM , Lian EC . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura . N Engl J Med. . 1998;339:1585–1594
  21. Van der Plas RM , Schiphorst ME , Huizinga EG , et al.   Von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura . Blood . 1999;93:3798–3802
  22. Daly AS , Hasegawa WS , Lipton JH , et al.   Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver . Transfus Apheresis Sci. . 2002;27:3–12
  23. Takatsuka H , Wakae T , Mori A , et al.   Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation . Bone Marrow Transplant . 2002;29:907–911
  24. Sarkodee-Adoo C , Sotirescu D , Sensenbrenner L , et al.   Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A . Transfusion . 2003;43:78–84
  25. Ljungman P , Brand R , Einsele H , et al.   Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation (an El megafile analysis) . Blood . 2003;102:4255–4260
  26. Lin TS , Zahrich D , Weller E , et al.   Risk factors for cytomegalovirus reactivation after CD+ T-cell-depleted allogeneic bone marrow transplantation . Transplantation . 2002;74:49–54
  27. Broers AEC , van der Holt R , van Esser JWJ , et al.   Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation . Blood . 2000;95:2240–2245
  28. Kroger N , Zabelina T , Kruger W , et al.   Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin . Br J Haematol. . 2001;113:1060–1071
  29. Meijer E , Dekker AW , Rozenberg-Arska M , et al.   Influence of cytomegalovirus seropositivity on outcome after T-cell-depleted bone marrow transplantation (contrasting results between recipients of grafts from related and unrelated donors) . Clin Infect Dis. . 2002;35:703–712
  30. Alessandrino EP , Martinelli G , Canevari A , et al.   Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombotic thrombocytopenic purpura . Bone Marrow Transplant . 2000;25:1217–1218
  31. Takatsuka H , Wakae T , Mori A , et al.   Endothelial damage caused by cytomegalovirus and human herpesvirus-6 . Bone Marrow Transplant . 2003;31:475–479
  32. Jeejeebhoy FM , Zaltzman JS . Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient (a new treatment strategy) . Transplantation . 1998;65:1645–1648
  33. Waiser J , Budde K , Rudolph B , et al.   De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection . Am J Kidney Dis. . 1999;34:556–559
  34. Fassas AB , Buddharaju LN , Rapoport A , et al.   Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation . Leuk Lymphoma . 2001;42:801–804
  35. Kalwak K , Moson I , Cwian J , et al.   A prospective analysis of immune recovery in children following allogeneic transplantation of T-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors . Transplant Proc. . 2003;35:1551–1555
  36. Bahlman FH , Song R , Boehm SM , et al.   Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure . Circulation . 2004;110:1006–1012
  37. Vesey DA , Cheung C , Endre PB , Johnson GG . Erythropoietin protects against ischaemic acute renal injury . Nephrol Dial Transplant. . 2004;19:348–355
  38. Vaziri ND , Zhou XJ , Liao SY . Erythropoietin enhances recovery from cisplatin-induced acute renal failure . Am J Physiol. . 1994;266:F360–F366
  39. Mori T , Okamoto S , Watanabe R , et al.   Successful treatment of bone marrow transplant-associated thrombotic microangiopathy with antithrombin-III . Am J Med. . 2002;112:81–82

PII: S1083-8791(05)00504-5

doi: 10.1016/j.bbmt.2005.07.012

Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 912-920 , November 2005

Article Tools

* Image Usage & Resolution